Literature DB >> 16741014

Endothelin-1 and PKC induce positive inotropy without affecting pHi in ventricular myocytes.

Misuk Kang1, Jeffery W Walker.   

Abstract

It has been proposed that intracellular alkalinization underlies the enhanced contractility of ventricular myocytes exposed to endothelin (ET)-1. The effects of ET-1 on the contractility and intracellular pH (pH(i)) were examined here in cultured adult rat ventricular myocytes by employing the pH-sensitive fluorescent dye SNARF-1. Variable pH(i) changes were observed on ET-1 stimulation. Most myocytes (n = 20 of 32) did not alkalinize, but showed an approximate 60% increase in twitch amplitude in response to ET-1. In the remaining myocytes (12 of 32), ET-1 induced an increase in pH(i) by 0.05 +/- 0.02 pH units with a similar approximate 60% increase in twitch amplitude. Therefore, there was no strong correlation between ET-1-mediated positive inotropy (enhanced contractility) and intracellular alkalinization. To determine whether ET-1 contractile and pH(i) responses were mediated by protein kinase C (PKC), yellow fluorescent protein (YFP)-fused dominant negative (dn) PKC constructs were used as isoform specific inhibitors. In dn-PKC-epsilon-YFP-expressing myocytes, the ET-1-mediated positive inotropic response was greatly diminished to 13 +/- 15%, but alkalinization was still observed. Expression of dn-PKC-delta-YFP also did not block alkalinization, but in this case the positive inotropic response was still observed. In a previous study, we showed that expression of PKC-delta and PKC-epsilon caused a strong positive inotropy on stimulation with phorbol 12,13-dibutyrate (PDBu). Using this system, PDBu failed to affect pH(i) in the majority of PKC expressing myocytes despite increases in twitch amplitudes of >60%. Overall, the poor correlation of positive inotropic responses and alkalinization was observed for ET-1 with and without dn-PKC constructs and for PDBu with and without wild-type PKC constructs. These results suggest that ET-1 produces positive inotropy via PKC-epsilon by mechanisms other than intracellular alkalinization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741014

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  A series of naphthalimide derivatives as intra and extracellular pH sensors.

Authors:  Yanqing Tian; Fengyu Su; Warner Weber; Vivek Nandakumar; Bradley R Shumway; Yuguang Jin; Xianfeng Zhou; Mark R Holl; Roger H Johnson; Deirdre R Meldrum
Journal:  Biomaterials       Date:  2010-07-08       Impact factor: 12.479

Review 2.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010

3.  PKC-ε mediates multiple endothelin-1 actions on systolic Ca2+ and contractility in ventricular myocytes.

Authors:  Misuk Kang; Ka Young Chung
Journal:  Biochem Biophys Res Commun       Date:  2012-06-12       Impact factor: 3.575

4.  The role of fibroblast - Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease.

Authors:  David Bode; Diana Lindner; Michael Schwarzl; Dirk Westermann; Peter Deissler; Uwe Primessnig; Niklas Hegemann; Lothar A Blatter; Sophie van Linthout; Carsten Tschöpe; Felix Schoenrath; Sajjad Soltani; Christof Stamm; Volker Duesterhoeft; Natale Rolim; Ulrik Wisløff; Christoph Knosalla; Volkmar Falk; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  J Mol Cell Cardiol       Date:  2019-04-18       Impact factor: 5.000

5.  Negative inotropic effects of endothelin-1 in mouse cardiomyocytes: evidence of a role for Na+-Ca2+ exchange.

Authors:  A F James
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

6.  Apelin increases cardiac contractility via protein kinase Cε- and extracellular signal-regulated kinase-dependent mechanisms.

Authors:  Ábel Perjés; Réka Skoumal; Olli Tenhunen; Attila Kónyi; Mihály Simon; Iván G Horváth; Risto Kerkelä; Heikki Ruskoaho; István Szokodi
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.